Moving toward personalized medicine for melanoma.

MELANOMA treatment; BIOLOGICAL assay; DERMATOLOGY; GENETICS; MEDICAL protocols; MELANOMA; MOLECULAR biology; GENETIC mutation; UNITED States. Food & Drug Administration; INDIVIDUALIZED medicine; EARLY detection of cancer

The article discusses highlights of a presentation on personalized medicine and molecular assays that help to classify and treat cutaneous melanoma, at the summer meeting of the American Academy of Dermatology held in New York in August 2015. Topics tackled are the correlation between mutational load in cutaneous melanoma and sun exposures, genomic and genetic characteristics in melanomas, and immunotherapy approaches to cytotoxic T-cells.